SlideShare a Scribd company logo
1 of 1
Download to read offline
Changes in cerebrovascular blood flow velocity during the Valsalva maneuver in
women throughout the menstrual cycle and in men
INTRODUCTION
METHODS
RESULTS
REFERENCES
PURPOSE
The purposes of this study were to investigate 1) changes in brain blood flow and
blood pressure in response to the Valsalva maneuver, and 2) changes in cardiovascular
variables that occur during a supine-sit-stand posture change protocol in men and
women throughout the menstrual cycle.
SUMMARY
Stephania Serna1, Simon Kim1, Christopher Hazlett1, Heather Edgell1
1School of Kinesiology and Health Sciences, York University, Toronto, ON, Canada
Women are well known have lower orthostatic tolerance compared to men
(Convertino, 1998). While the exact mechanisms for greater orthostatic intolerance in
women are unclear, changes throughout the menstrual cycle likely play a role. Indeed,
women in the early follicular phase experience greater sensations of light-headedness
compared to the luteal phase (Peggs et al. 2012).
There are many potential areas where female sex hormones can affect the
cardiovascular and autonomic responses to stressors. For example, estrogen has
sympathoinhibitory effects, yet progesterone has been suggested to be
sympathoexcitatory (Carter et al. 2013). These findings suggest that changes in
estrogen and progesterone have the ability to change a woman’s response to
orthostatic stress.
We hypothesized that women in the early follicular phase of the menstrual cycle will
have reduced brain blood flow and cerebral perfusion pressure during a stand test
compared to men and compared to the luteal phase. We further hypothesize that
women in the early follicular phase will have a reduced ability to recover brain blood
flow velocity during late phase II of the Valsalva maneuver compared to men and the
luteal phase.
Healthy men (n=11) and women (n=9) were recruited (age 18-30). Women were
studied in the follicular (Day 2-5; low levels of estrogen and progesterone) and luteal
(Day 18-24; high levels of estrogen and progesterone) phases of menstruation in a
repeated measures design. None were taking oral contraceptives. Brain blood flow
velocity was measured from the middle cerebral artery (MCA) using Transcranial
Doppler (Multigon). A 2 MHz ultrasound probe was positioned on the temple and
peak velocity was obtained. Continuous blood pressure and cardiac output were
measured using a Finometer Pro.
Participants were studied during a supine Valsalva maneuver test (exhalation to
40mmHg for 15 seconds). Cerebrovascular Valsalva ratio (CVR; change in cerebral
diastolic blood flow velocity/time during late phase II) and Centroperipheral Valsalva
ratio (CPVR; CVR/(change in diastolic blood pressure/time) during late phase II)
were calculated (Wallasch et al. 2011; Figure 1).
After the Valsalva maneuver, participants rested supine for 5 minutes then moved in a
continuous motion from supine to a seated position for 5 minutes, and then stood up
for 10 minutes (Figure 2). All data were recorded in LabChart Pro 8.0 and presented
as mean ± standard error. All data were compared using one-way ANOVA, one-way
repeated measures (RM) ANOVA, or two-way RM ANOVA.
Figure 3: Cerebrovascular Valsalva Ratio
(CVR) was compared between: men vs.
follicular phase (p=0.012), men vs. luteal
phase (p=0.061), and follicular vs. luteal
phases (p= 0.570).
Figure 5: Heart rate during the supine-sit-
stand protocol in men and women in the
follicular and luteal phases of the menstrual
cycle. * indicates a main effect of posture in
all groups.
Figure 8: Middle cerebral artery (MCA) brain
blood flow velocity during the supine-sit-stand
protocol in men and women in the follicular and
luteal phases of the menstrual cycle. * indicates a
significant drop of MCA velocity during standing
in all groups.
Figure 4: Centroperipheral Valsalva Ratio
(CPVR) was compared between: men vs.
follicular phase (p=0.870), men vs. luteal
phase (p=0.423), and follicular vs. luteal
phases (p= 0.464).
Valsalva maneuver: Women have higher CVR during Valsalva in comparison to men,
yet there were no significant differences found between sexes for CPVR suggesting
that women have greater increases of both MCA velocity and blood pressure over time
during late phase II. There were no effects of menstrual cycle.
Supine-sit-stand: Heart rate increased equally from supine to standing in all
participants. Interestingly, this was not enough to maintain cardiac output in women
during the follicular phase implying a reduced stroke volume. CPP was lower during
standing in men and women in the follicular phase yet maintained in the luteal phase.
MCA velocity dropped equally in all groups with standing.
Carter et al. (2013) Hypertension 61(2): 395-9.
Convertino, V. A. (1998) Am. J. Physiol. Regul. Integr. Comp. Physiol. 275: R1909–R1920
Peggs et al. (2012) Int J Gynaecol Obstet 118(3): 242-6.
Wallasch et al. (2011) Functional Neurology 26(4):223-227
Figure 2: Representative data from posture
change model. Approximately 1 minute
from each posture is shown. MCA is middle
cerebral artery. ET-CO2 is end-tidal carbon
dioxide.
Figure 1: Representative data during the
Valsalva Maneuver. MCA is middle cerebral
artery. Late phase 2 is indicated.
Figure 6: Cardiac output during the supine-
sit-stand protocol in men and women in the
follicular phases of the menstrual cycle.
* indicates a significant drop in cardiac
output in the follicular compared to the luteal
phase. † indicates a significant effect of sex.
FUNDING
Faculty of Health, York University
CONCLUSIONS AND FUTURE DIRECTIONS
Late phase 2
0	
0.2	
0.4	
0.6	
0.8	
1	
1.2	
1.4	
1.6	
1.8	
2	
Males	 Follicular	 Luteal		
CPVR		(cm/mmHg	x	s)	
50	
55	
60	
65	
70	
75	
80	
85	
90	
95	
100	
Supine	 Seated	 Standing	
Heart	rate	(bpm)	
Males	
Follicular	
Luteal		
*
0	
0.5	
1	
1.5	
2	
2.5	
3	
3.5	
4	
4.5	
Men	 	Follicular	 	Luteal	
CVR		(cm/s2)	
*
2	
3	
4	
5	
6	
7	
8	
Supine	 Seated	 Standing	
Cardiac	output	(L/min)	
Males	
Follicular	
Luteal		
*
†
Figure 7: Cerebral perfusion pressure (CPP)
during the supine-sit-stand protocol in men and
women in the follicular and luteal phases of the
menstrual cycle. * indicates a significant drop of
CPP during standing in men and follicular phase.
70	
75	
80	
85	
90	
95	
100	
105	
110	
Supine	 Seated	 Standing	
CPP		(mmHg)		
Males	
Follicular	
Luteal		
*
35	
40	
45	
50	
55	
60	
65	
70	
75	
Supine	 Seated	 Standing	
MCA	velocity	(cm/s)	
Males	
Follicular	
Luteal		
*
*
Conclusions: Contrary to our hypotheses, women in the follicular phase did not
exhibit lower MCA velocity during orthostatic stress nor a reduced ability to recover
MCA velocity during Valsalva compared to men or the luteal phase. However, in the
follicular phase women did have lower cardiac output and a reduction in CPP during
standing compared to the luteal phase suggesting that reductions in stroke volume
could be responsible for greater lightheadedness in the follicular phase. Future
directions: We will analyze end-tidal CO2 throughout the posture change model to
determine if any changes in brain blood flow velocity are due to changes in arterial
CO2. Further we intend to analyze various resistance indices such as pulsatility index,
resistance index and cerebrovascular resistance index. Lastly, we will expand the
current study by recruiting women that are taking oral contraceptives to determine if
there are differences between natural and pharmaceutical sex hormones.

More Related Content

What's hot

App g upright mobility
App g upright mobilityApp g upright mobility
App g upright mobilitySandra Hess
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fractionVijay Yadav
 
Managing Ventricular Arrhythmia In First In Man Studies A Nada
Managing Ventricular Arrhythmia In First In Man Studies A NadaManaging Ventricular Arrhythmia In First In Man Studies A Nada
Managing Ventricular Arrhythmia In First In Man Studies A Nadaadelnada
 
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...Boehringer Ingelheim Pharmaceuticals, Inc.
 
Management of anticoagulation in lvad recipients
Management of anticoagulation in lvad recipientsManagement of anticoagulation in lvad recipients
Management of anticoagulation in lvad recipientsdrucsamal
 
Seminar presentation 30 sept 2020
Seminar presentation 30 sept 2020Seminar presentation 30 sept 2020
Seminar presentation 30 sept 2020SumaiyaShams
 
Cardio cerebral resuscitation
Cardio cerebral resuscitationCardio cerebral resuscitation
Cardio cerebral resuscitationToufiqur Rahman
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fractionRajat Jain
 
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav YawalkarHeart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkarvaibhavyawalkar
 
Phenotype specific treatment of heart failure with preserved ejection
Phenotype specific treatment of heart failure with preserved ejectionPhenotype specific treatment of heart failure with preserved ejection
Phenotype specific treatment of heart failure with preserved ejectionsoumyasil
 
Lankhorst et al-2015-anaesthesia
Lankhorst et al-2015-anaesthesiaLankhorst et al-2015-anaesthesia
Lankhorst et al-2015-anaesthesiasamirsharshar
 
Prediction and Prevention in Sudden Cardiac Death
Prediction and Prevention in Sudden Cardiac DeathPrediction and Prevention in Sudden Cardiac Death
Prediction and Prevention in Sudden Cardiac DeathApollo Hospitals
 

What's hot (20)

Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac death
 
App g upright mobility
App g upright mobilityApp g upright mobility
App g upright mobility
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 
Step by step management of stage 2& 3 Hypertension
Step by step management of stage 2& 3 HypertensionStep by step management of stage 2& 3 Hypertension
Step by step management of stage 2& 3 Hypertension
 
Managing Ventricular Arrhythmia In First In Man Studies A Nada
Managing Ventricular Arrhythmia In First In Man Studies A NadaManaging Ventricular Arrhythmia In First In Man Studies A Nada
Managing Ventricular Arrhythmia In First In Man Studies A Nada
 
ECG for the intensivists
ECG for the intensivistsECG for the intensivists
ECG for the intensivists
 
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
Defining Moments in Non-Valvular Atrial Fibrillation: Pathophysiology and con...
 
Approach to HFrEF
Approach to HFrEFApproach to HFrEF
Approach to HFrEF
 
Management of anticoagulation in lvad recipients
Management of anticoagulation in lvad recipientsManagement of anticoagulation in lvad recipients
Management of anticoagulation in lvad recipients
 
Seminar presentation 30 sept 2020
Seminar presentation 30 sept 2020Seminar presentation 30 sept 2020
Seminar presentation 30 sept 2020
 
Cardio cerebral resuscitation
Cardio cerebral resuscitationCardio cerebral resuscitation
Cardio cerebral resuscitation
 
Heart failure with preserved ejection fraction
Heart failure with preserved ejection fractionHeart failure with preserved ejection fraction
Heart failure with preserved ejection fraction
 
Arizona Af Albers
Arizona Af AlbersArizona Af Albers
Arizona Af Albers
 
Coitus and CAD
Coitus and CADCoitus and CAD
Coitus and CAD
 
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav YawalkarHeart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
Heart Failure with Preserved Ejection Fraction By DR. Vaibhav Yawalkar
 
HFPEF
HFPEFHFPEF
HFPEF
 
Phenotype specific treatment of heart failure with preserved ejection
Phenotype specific treatment of heart failure with preserved ejectionPhenotype specific treatment of heart failure with preserved ejection
Phenotype specific treatment of heart failure with preserved ejection
 
Lankhorst et al-2015-anaesthesia
Lankhorst et al-2015-anaesthesiaLankhorst et al-2015-anaesthesia
Lankhorst et al-2015-anaesthesia
 
Arrhythmia: ECG-Tachycardia_20120909_中區
Arrhythmia: ECG-Tachycardia_20120909_中區Arrhythmia: ECG-Tachycardia_20120909_中區
Arrhythmia: ECG-Tachycardia_20120909_中區
 
Prediction and Prevention in Sudden Cardiac Death
Prediction and Prevention in Sudden Cardiac DeathPrediction and Prevention in Sudden Cardiac Death
Prediction and Prevention in Sudden Cardiac Death
 

Similar to Stephania's OEP Poster

785ISSN 1745-5057Womens Health (2010) 6(6), 785–78710.2217WH.docx
785ISSN 1745-5057Womens Health (2010) 6(6), 785–78710.2217WH.docx785ISSN 1745-5057Womens Health (2010) 6(6), 785–78710.2217WH.docx
785ISSN 1745-5057Womens Health (2010) 6(6), 785–78710.2217WH.docxsleeperharwell
 
Cardiac Pacing for Heart Failure Patients
Cardiac Pacing for Heart Failure PatientsCardiac Pacing for Heart Failure Patients
Cardiac Pacing for Heart Failure PatientsGeorge Yanulis
 
Presentation On My Dissertation Research In Crm
Presentation On My Dissertation Research In  CrmPresentation On My Dissertation Research In  Crm
Presentation On My Dissertation Research In Crmguest3dbcb97
 
Presentation On My Dissertation Research In Crm
Presentation On My Dissertation Research In  CrmPresentation On My Dissertation Research In  Crm
Presentation On My Dissertation Research In Crmguestdb4126f
 
Functional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac diseaseFunctional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac diseaseLuis Carlos Murillo Valencia
 
Functional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the  fetus with non cardiac diseaseFunctional echocardiography in the  fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac diseasegisa_legal
 
Functional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac diseaseFunctional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac diseasegisa_legal
 
Monitoring of Neonatal Haemodynamics
Monitoring of Neonatal HaemodynamicsMonitoring of Neonatal Haemodynamics
Monitoring of Neonatal HaemodynamicsAyman Abou Mehrem
 
Role of ultrasound in iugr
Role of ultrasound in iugrRole of ultrasound in iugr
Role of ultrasound in iugrchidananda patro
 
A Speckle Tracking Echocardiographic Study for Correlation Between Global Lef...
A Speckle Tracking Echocardiographic Study for Correlation Between Global Lef...A Speckle Tracking Echocardiographic Study for Correlation Between Global Lef...
A Speckle Tracking Echocardiographic Study for Correlation Between Global Lef...Premier Publishers
 
Blood Pressure Responses To Small And Large Muscle Dynamic Exercise In Older ...
Blood Pressure Responses To Small And Large Muscle Dynamic Exercise In Older ...Blood Pressure Responses To Small And Large Muscle Dynamic Exercise In Older ...
Blood Pressure Responses To Small And Large Muscle Dynamic Exercise In Older ...dgrinnell
 
Fetal and maternal interaction in pre-eclampsia
Fetal and maternal interaction in pre-eclampsiaFetal and maternal interaction in pre-eclampsia
Fetal and maternal interaction in pre-eclampsiaIgor Lakhno
 
Evolution of circadian rhythm
Evolution of circadian rhythmEvolution of circadian rhythm
Evolution of circadian rhythmdrammarmehdi
 
Updates in Group 5 PH: ESRD, SCD, MPD
Updates in Group 5 PH: ESRD, SCD, MPDUpdates in Group 5 PH: ESRD, SCD, MPD
Updates in Group 5 PH: ESRD, SCD, MPDDuke Heart
 
Murley Meghan Thesis Female Heart Rate Variability - A Pilot Reliability Study
Murley Meghan Thesis Female Heart Rate Variability - A Pilot Reliability StudyMurley Meghan Thesis Female Heart Rate Variability - A Pilot Reliability Study
Murley Meghan Thesis Female Heart Rate Variability - A Pilot Reliability StudyMeghan Murley
 

Similar to Stephania's OEP Poster (20)

Poster Esformes
Poster EsformesPoster Esformes
Poster Esformes
 
785ISSN 1745-5057Womens Health (2010) 6(6), 785–78710.2217WH.docx
785ISSN 1745-5057Womens Health (2010) 6(6), 785–78710.2217WH.docx785ISSN 1745-5057Womens Health (2010) 6(6), 785–78710.2217WH.docx
785ISSN 1745-5057Womens Health (2010) 6(6), 785–78710.2217WH.docx
 
Cardiac Pacing MS PPT
Cardiac Pacing MS PPTCardiac Pacing MS PPT
Cardiac Pacing MS PPT
 
Cardiac Pacing for Heart Failure Patients
Cardiac Pacing for Heart Failure PatientsCardiac Pacing for Heart Failure Patients
Cardiac Pacing for Heart Failure Patients
 
Presentation On My Dissertation Research In Crm
Presentation On My Dissertation Research In  CrmPresentation On My Dissertation Research In  Crm
Presentation On My Dissertation Research In Crm
 
Presentation On My Dissertation Research In Crm
Presentation On My Dissertation Research In  CrmPresentation On My Dissertation Research In  Crm
Presentation On My Dissertation Research In Crm
 
PPT for cardiac pacing
PPT for cardiac pacingPPT for cardiac pacing
PPT for cardiac pacing
 
Functional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac diseaseFunctional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac disease
 
Functional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the  fetus with non cardiac diseaseFunctional echocardiography in the  fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac disease
 
Functional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac diseaseFunctional echocardiography in the fetus with non cardiac disease
Functional echocardiography in the fetus with non cardiac disease
 
Monitoring of Neonatal Haemodynamics
Monitoring of Neonatal HaemodynamicsMonitoring of Neonatal Haemodynamics
Monitoring of Neonatal Haemodynamics
 
Role of ultrasound in iugr
Role of ultrasound in iugrRole of ultrasound in iugr
Role of ultrasound in iugr
 
Hyperkalemia
HyperkalemiaHyperkalemia
Hyperkalemia
 
A Speckle Tracking Echocardiographic Study for Correlation Between Global Lef...
A Speckle Tracking Echocardiographic Study for Correlation Between Global Lef...A Speckle Tracking Echocardiographic Study for Correlation Between Global Lef...
A Speckle Tracking Echocardiographic Study for Correlation Between Global Lef...
 
Blood Pressure Responses To Small And Large Muscle Dynamic Exercise In Older ...
Blood Pressure Responses To Small And Large Muscle Dynamic Exercise In Older ...Blood Pressure Responses To Small And Large Muscle Dynamic Exercise In Older ...
Blood Pressure Responses To Small And Large Muscle Dynamic Exercise In Older ...
 
Fetal and maternal interaction in pre-eclampsia
Fetal and maternal interaction in pre-eclampsiaFetal and maternal interaction in pre-eclampsia
Fetal and maternal interaction in pre-eclampsia
 
Anest turp
Anest turpAnest turp
Anest turp
 
Evolution of circadian rhythm
Evolution of circadian rhythmEvolution of circadian rhythm
Evolution of circadian rhythm
 
Updates in Group 5 PH: ESRD, SCD, MPD
Updates in Group 5 PH: ESRD, SCD, MPDUpdates in Group 5 PH: ESRD, SCD, MPD
Updates in Group 5 PH: ESRD, SCD, MPD
 
Murley Meghan Thesis Female Heart Rate Variability - A Pilot Reliability Study
Murley Meghan Thesis Female Heart Rate Variability - A Pilot Reliability StudyMurley Meghan Thesis Female Heart Rate Variability - A Pilot Reliability Study
Murley Meghan Thesis Female Heart Rate Variability - A Pilot Reliability Study
 

Stephania's OEP Poster

  • 1. Changes in cerebrovascular blood flow velocity during the Valsalva maneuver in women throughout the menstrual cycle and in men INTRODUCTION METHODS RESULTS REFERENCES PURPOSE The purposes of this study were to investigate 1) changes in brain blood flow and blood pressure in response to the Valsalva maneuver, and 2) changes in cardiovascular variables that occur during a supine-sit-stand posture change protocol in men and women throughout the menstrual cycle. SUMMARY Stephania Serna1, Simon Kim1, Christopher Hazlett1, Heather Edgell1 1School of Kinesiology and Health Sciences, York University, Toronto, ON, Canada Women are well known have lower orthostatic tolerance compared to men (Convertino, 1998). While the exact mechanisms for greater orthostatic intolerance in women are unclear, changes throughout the menstrual cycle likely play a role. Indeed, women in the early follicular phase experience greater sensations of light-headedness compared to the luteal phase (Peggs et al. 2012). There are many potential areas where female sex hormones can affect the cardiovascular and autonomic responses to stressors. For example, estrogen has sympathoinhibitory effects, yet progesterone has been suggested to be sympathoexcitatory (Carter et al. 2013). These findings suggest that changes in estrogen and progesterone have the ability to change a woman’s response to orthostatic stress. We hypothesized that women in the early follicular phase of the menstrual cycle will have reduced brain blood flow and cerebral perfusion pressure during a stand test compared to men and compared to the luteal phase. We further hypothesize that women in the early follicular phase will have a reduced ability to recover brain blood flow velocity during late phase II of the Valsalva maneuver compared to men and the luteal phase. Healthy men (n=11) and women (n=9) were recruited (age 18-30). Women were studied in the follicular (Day 2-5; low levels of estrogen and progesterone) and luteal (Day 18-24; high levels of estrogen and progesterone) phases of menstruation in a repeated measures design. None were taking oral contraceptives. Brain blood flow velocity was measured from the middle cerebral artery (MCA) using Transcranial Doppler (Multigon). A 2 MHz ultrasound probe was positioned on the temple and peak velocity was obtained. Continuous blood pressure and cardiac output were measured using a Finometer Pro. Participants were studied during a supine Valsalva maneuver test (exhalation to 40mmHg for 15 seconds). Cerebrovascular Valsalva ratio (CVR; change in cerebral diastolic blood flow velocity/time during late phase II) and Centroperipheral Valsalva ratio (CPVR; CVR/(change in diastolic blood pressure/time) during late phase II) were calculated (Wallasch et al. 2011; Figure 1). After the Valsalva maneuver, participants rested supine for 5 minutes then moved in a continuous motion from supine to a seated position for 5 minutes, and then stood up for 10 minutes (Figure 2). All data were recorded in LabChart Pro 8.0 and presented as mean ± standard error. All data were compared using one-way ANOVA, one-way repeated measures (RM) ANOVA, or two-way RM ANOVA. Figure 3: Cerebrovascular Valsalva Ratio (CVR) was compared between: men vs. follicular phase (p=0.012), men vs. luteal phase (p=0.061), and follicular vs. luteal phases (p= 0.570). Figure 5: Heart rate during the supine-sit- stand protocol in men and women in the follicular and luteal phases of the menstrual cycle. * indicates a main effect of posture in all groups. Figure 8: Middle cerebral artery (MCA) brain blood flow velocity during the supine-sit-stand protocol in men and women in the follicular and luteal phases of the menstrual cycle. * indicates a significant drop of MCA velocity during standing in all groups. Figure 4: Centroperipheral Valsalva Ratio (CPVR) was compared between: men vs. follicular phase (p=0.870), men vs. luteal phase (p=0.423), and follicular vs. luteal phases (p= 0.464). Valsalva maneuver: Women have higher CVR during Valsalva in comparison to men, yet there were no significant differences found between sexes for CPVR suggesting that women have greater increases of both MCA velocity and blood pressure over time during late phase II. There were no effects of menstrual cycle. Supine-sit-stand: Heart rate increased equally from supine to standing in all participants. Interestingly, this was not enough to maintain cardiac output in women during the follicular phase implying a reduced stroke volume. CPP was lower during standing in men and women in the follicular phase yet maintained in the luteal phase. MCA velocity dropped equally in all groups with standing. Carter et al. (2013) Hypertension 61(2): 395-9. Convertino, V. A. (1998) Am. J. Physiol. Regul. Integr. Comp. Physiol. 275: R1909–R1920 Peggs et al. (2012) Int J Gynaecol Obstet 118(3): 242-6. Wallasch et al. (2011) Functional Neurology 26(4):223-227 Figure 2: Representative data from posture change model. Approximately 1 minute from each posture is shown. MCA is middle cerebral artery. ET-CO2 is end-tidal carbon dioxide. Figure 1: Representative data during the Valsalva Maneuver. MCA is middle cerebral artery. Late phase 2 is indicated. Figure 6: Cardiac output during the supine- sit-stand protocol in men and women in the follicular phases of the menstrual cycle. * indicates a significant drop in cardiac output in the follicular compared to the luteal phase. † indicates a significant effect of sex. FUNDING Faculty of Health, York University CONCLUSIONS AND FUTURE DIRECTIONS Late phase 2 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2 Males Follicular Luteal CPVR (cm/mmHg x s) 50 55 60 65 70 75 80 85 90 95 100 Supine Seated Standing Heart rate (bpm) Males Follicular Luteal * 0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 Men Follicular Luteal CVR (cm/s2) * 2 3 4 5 6 7 8 Supine Seated Standing Cardiac output (L/min) Males Follicular Luteal * † Figure 7: Cerebral perfusion pressure (CPP) during the supine-sit-stand protocol in men and women in the follicular and luteal phases of the menstrual cycle. * indicates a significant drop of CPP during standing in men and follicular phase. 70 75 80 85 90 95 100 105 110 Supine Seated Standing CPP (mmHg) Males Follicular Luteal * 35 40 45 50 55 60 65 70 75 Supine Seated Standing MCA velocity (cm/s) Males Follicular Luteal * * Conclusions: Contrary to our hypotheses, women in the follicular phase did not exhibit lower MCA velocity during orthostatic stress nor a reduced ability to recover MCA velocity during Valsalva compared to men or the luteal phase. However, in the follicular phase women did have lower cardiac output and a reduction in CPP during standing compared to the luteal phase suggesting that reductions in stroke volume could be responsible for greater lightheadedness in the follicular phase. Future directions: We will analyze end-tidal CO2 throughout the posture change model to determine if any changes in brain blood flow velocity are due to changes in arterial CO2. Further we intend to analyze various resistance indices such as pulsatility index, resistance index and cerebrovascular resistance index. Lastly, we will expand the current study by recruiting women that are taking oral contraceptives to determine if there are differences between natural and pharmaceutical sex hormones.